2024-09-10 2025-09-30 2025-09-30 false 15947501 Prevalent Care Limited 87100Residential nursing care facilities iso4217:GBP xbrli:pure 159475012024-09-10 159475012025-09-30 159475012024-09-10 2025-09-30 15947501bus:SmallEntities2024-09-10 2025-09-30 15947501bus:AuditExempt-NoAccountantsReport2024-09-10 2025-09-30 15947501bus:FullAccounts2024-09-10 2025-09-30 15947501core:WithinOneYear2025-09-30 15947501core:AfterOneYear2025-09-30 15947501core:WithinOneYear2024-09-10 2025-09-30 15947501core:AfterOneYear2024-09-10 2025-09-30 15947501core:CurrentFinancialInstruments2025-09-30 15947501core:Non-currentFinancialInstruments2025-09-30 15947501core:CurrentFinancialInstruments2024-09-10 2025-09-30 15947501core:Non-currentFinancialInstruments2024-09-10 2025-09-30 15947501core:LandBuildings2024-09-10 2025-09-30 15947501core:FurnitureFittings2024-09-10 2025-09-30 15947501core:OfficeEquipment2024-09-10 2025-09-30 15947501core:Vehicles2024-09-10 2025-09-30 15947501core:PlantMachinery2024-09-10 2025-09-30 15947501core:OtherPropertyPlantEquipment2024-09-10 2025-09-30 15947501core:LandBuildings2025-09-30 15947501core:PlantMachinery2025-09-30 15947501core:Vehicles2025-09-30 15947501core:FurnitureFittings2025-09-30 15947501core:OfficeEquipment2025-09-30 15947501core:OtherPropertyPlantEquipment2025-09-30 15947501core:Right-of-useAssets2024-09-10 2025-09-30 15947501core:Right-of-useAssets2025-09-30 15947501core:Goodwill2024-09-10 2025-09-30 15947501core:PatentsTrademarksLicencesConcessionsSimilar2024-09-10 2025-09-30 15947501core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-09-10 2025-09-30 15947501core:OtherResidualIntangibleAssets2024-09-10 2025-09-30 15947501core:Goodwill2025-09-30 15947501core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-09-30 15947501core:PatentsTrademarksLicencesConcessionsSimilar2025-09-30 15947501core:OtherResidualIntangibleAssets2025-09-30 15947501dpl:CostSales2024-09-10 2025-09-30 15947501dpl:AdministrativeExpenses2024-09-10 2025-09-30 15947501dpl:DistributionCosts2024-09-10 2025-09-3015947501core:ShareCapital2025-09-30 15947501core:SharePremium2025-09-30 15947501core:RevaluationReserve2025-09-30 15947501core:OtherReservesSubtotal2025-09-30 15947501core:ShareCapitalPreferenceShares2025-09-30 15947501core:CapitalRedemptionReserve2025-09-30 15947501core:OtherCapitalReserve2025-09-30 15947501core:RetainedEarningsAccumulatedLosses2025-09-3015947501core:ShareCapital2024-09-10 2025-09-30 15947501core:SharePremium2024-09-10 2025-09-30 15947501core:RevaluationReserve2024-09-10 2025-09-30 15947501core:OtherReservesSubtotal2024-09-10 2025-09-30 15947501core:RetainedEarningsAccumulatedLosses2024-09-10 2025-09-301594750112024-09-10 2025-09-30 1594750122024-09-10 2025-09-3015947501core:ShareCapital12024-09-10 2025-09-30 15947501core:ShareCapital22024-09-10 2025-09-3015947501core:SharePremium12024-09-10 2025-09-30 15947501core:SharePremium22024-09-10 2025-09-3015947501core:RevaluationReserve12024-09-10 2025-09-30 15947501core:RevaluationReserve22024-09-10 2025-09-3015947501core:RetainedEarningsAccumulatedLosses12024-09-10 2025-09-30 15947501core:RetainedEarningsAccumulatedLosses22024-09-10 2025-09-301594750112024-09-10 2025-09-3015947501core:Non-currentFinancialInstrumentscore:CostValuation2024-09-10 15947501core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3015947501core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-09-10 15947501core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-09-30 15947501core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-30 15947501core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-09-3015947501core:Non-currentFinancialInstruments2025-09-30 15947501core:Non-currentFinancialInstruments2024-09-0915947501bus:Director12024-09-10 2025-09-3015947501bus:Director22024-09-10 2025-09-3015947501bus:PrivateLimitedCompanyLtd2024-09-10 2025-09-30
Prevalent Care Limited
Unaudited Financial Statements
for the period ended 30 September 2025
Company registration number 15947501
(England and Wales)

Company Information

For the period 10 September 2024 to 30 September 2025
Directors Ogundero, Babatunde
Chifamba, Tatenda

Company secretaries Chifamba, Tatenda
Ogundero, Babatunde

Registered office 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Registered number 15947501

Accountant 2020 ACCOUNTANCY
Bourne Space
Bourne House
23 Hinton Road
Bournemouth
Bournemouth
BH1 2EF

Statement of Financial Position

As at 30 September 2025
Notes
2025
£
£
Current assets
Cash at bank and in hand
56
56
Creditors
Amounts falling due within one year
 4
(4,237)
(4,237)
Net current assets (liabilities)
(4,181)
Total assets less current liabilities
(4,181)
Net assets (liabilities)
(4,181)
Capital and reserves
Called up share capital
200
Profit and loss account
(4,381)
Total equity
(4,181)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 10 June 2026 and are signed on its behalf by:

Ogundero, Babatunde
Ogundero, Babatunde
Director
Chifamba, Tatenda
Chifamba, Tatenda
Director

Company registration number 15947501

Notes to the Financial Statements

For the period 10 September 2024 to 30 September 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 0.

4. Creditors due within one year
2025
£
Directors loan account
3,697
Accruals and deferred income
540
Total
4,237